Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces clinical trial findings showing that trastuzumab (…

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress…

Within the first 5 years after the birth of a child, women are considered at an increased risk of developing metastatic breast cancer. Why that happens has been considered a puzzle but the fact…

Ovarian cancer is the most deadly gynecological kind, it claims the lives of more than 50% of women who are diagnosed Ovarian cancer is often diagnosed late and develops a resistance to chemotherapy…

Retinoblastoma is a childhood retinal tumor usually affecting children ages one to two and the most common malignant tumor of the eye in children. Left untreated, retinoblastoma can be fatal or…

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort, according to two studies published in  OncoImmunology…

Head and neck cancer underway. Credit: Akira Kouchiyama, CC BY-SA By Emma King, University of Southampton and Christian Ottensmeier, University of Southampton Immune cells in the blood primarily…

An international research consortium has found that longer telomeres increase the risk of melanoma. Telomeres are a part of the genome that function like the plastic caps of your shoelaces, which…

Men who had moderate baldness affecting both the front and the crown of their head by age 45 were at a 40% increased risk of developing aggressive prostate cancer than men with no baldness, according…

The genetic mutation BRAFV600E secretes a protein that promotes the growth of melanoma tumor cells and modify the network of normal cells around the tumor to support the disease's progression,…